A basic study on the global coagulation and fibrinolysis of hyperlipaemic and atherosclerotic patients: Part 2. Plasminogen activator, plasminogen, α2-Macroglobulin in atherosclerosis and endogenous hypertriglyceridaemia
- 31 December 1970
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 12 (3) , 427-437
- https://doi.org/10.1016/0021-9150(70)90047-x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- FIBRINOLYTIC ACTIVITY AND CORONARY-ARTERY DISEASEThe Lancet, 1968
- FIBRINOLYTIC ACTIVITY RELATED TO AGE IN SURVIVORS OF MYOCARDIAL INFARCTIONThe Lancet, 1966
- Fibrinolysis Related to Age in MenBritish Journal of Haematology, 1963
- Studies of Coagulation and Fibrinolysis of the Arterial and Venous Blood in Normal Subjects and Patients with AtherosclerosisCirculation, 1963
- LIPÆMIA AND BLOOD-COAGULATION DEFECTS IN RELATION TO ISCHÆMIC HEART-DISEASEThe Lancet, 1961
- Reduced Fibrinolytic Activity of Atherosclerotic Sera caused by an Increase in Low-density Lipoproteins in BloodNature, 1961
- Studies of inhibition of the plasmin-plasminogen fibrinolytic enzyme system in patients with myocardial infarction∗The American Journal of Cardiology, 1960
- STUDIES ON THE THROMBOLYTIC ACTIVITY OF HUMAN PLASMA *Journal of Clinical Investigation, 1960
- FIBRINOLYTIC ACTIVITY OF THE BLOOD IN INTERMITTENT CLAUDICATIONThe Lancet, 1959
- FIBRINOLYSIS IN MYOCARDIAL INFARCTIONHeart, 1958